Proteomics: drug target discovery on an industrial scale
- 1 December 2002
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 20 (12) , s45-s51
- https://doi.org/10.1016/s1471-1931(02)00199-4
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Realistic Pathologic Classification of Acute Myeloid LeukemiasAmerican Journal of Clinical Pathology, 2001
- Large-scale analysis of the yeast proteome by multidimensional protein identification technologyNature Biotechnology, 2001
- Evaluation of two-dimensional gel electrophoresis-based proteome analysis technologyProceedings of the National Academy of Sciences, 2000
- Morphology and Classification of Acute Myeloid LeukemiasClinics In Laboratory Medicine, 2000
- Mass spectrometric identification of proteins released from mitochondria undergoing permeability transitionCell Death & Differentiation, 2000
- Purification and biochemical characterization of interchromatin granule clustersThe EMBO Journal, 1999
- Direct analysis of protein complexes using mass spectrometryNature Biotechnology, 1999
- A comprehensive protein ressource for the study of bladder cancer: http://biobase.dk/cgi-bin/celisElectrophoresis, 1999
- The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis — Preliminary findingsElectrophoresis, 1999
- Direct Analysis and Identification of Proteins in Mixtures by LC/MS/MS and Database Searching at the Low-Femtomole LevelAnalytical Chemistry, 1997